TGFB1 and tuberculosis: Inhibiting TGF-β1 presents clinical challenges because of its pleotropic physiologic importance, but our study highlights the importance of cytotoxic T-cell effector function in bacterial clearance and suggests stimulating cytotoxic T cells may also have therapeutic value in treating TB.